These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32471699)

  • 1. Survival Outcomes of Treatment with Radiofrequency Ablation, Stereotactic Body Radiotherapy, or Sublobar Resection for Patients with Clinical Stage I Non-Small-Cell Lung Cancer: A Single-Center Evaluation.
    Iguchi T; Hiraki T; Matsui Y; Mitsuhashi T; Katayama N; Katsui K; Soh J; Sakurai J; Gobara H; Toyooka S; Kanazawa S
    J Vasc Interv Radiol; 2020 Jul; 31(7):1044-1051. PubMed ID: 32471699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sublobar resection compared with stereotactic body radiation therapy and ablation for early stage non-small cell lung cancer: A National Cancer Database study.
    Wu J; Bai HX; Chan L; Su C; Zhang PJ; Yang L; Zhang Z
    J Thorac Cardiovasc Surg; 2020 Nov; 160(5):1350-1357.e11. PubMed ID: 32033815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A National Cancer Database Analysis of Radiofrequency Ablation versus Stereotactic Body Radiotherapy in Early-Stage Non-Small Cell Lung Cancer.
    Lam A; Yoshida EJ; Bui K; Fernando D; Nelson K; Abi-Jaoudeh N
    J Vasc Interv Radiol; 2018 Sep; 29(9):1211-1217.e1. PubMed ID: 30061058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis.
    Matsuo Y; Chen F; Hamaji M; Kawaguchi A; Ueki N; Nagata Y; Sonobe M; Morita S; Date H; Hiraoka M
    Eur J Cancer; 2014 Nov; 50(17):2932-8. PubMed ID: 25281527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison Between Stereotactic Radiotherapy and Sublobar Resection for Non-Small Cell Lung Cancer.
    Tamura M; Matsumoto I; Tanaka Y; Saito D; Yoshida S; Kakegawa S; Kumano T; Shimizu Y; Tamamura H; Takanaka T; Takemura H
    Ann Thorac Surg; 2019 May; 107(5):1544-1550. PubMed ID: 30458155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic body radiotherapy versus percutaneous local tumor ablation for early-stage non-small cell lung cancer.
    Ager BJ; Wells SM; Gruhl JD; Stoddard GJ; Tao R; Kokeny KE; Hitchcock YJ
    Lung Cancer; 2019 Dec; 138():6-12. PubMed ID: 31593894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is stereotactic ablative radiotherapy equivalent to sublobar resection in high-risk surgical patients with stage I non-small-cell lung cancer?
    Mahmood S; Bilal H; Faivre-Finn C; Shah R
    Interact Cardiovasc Thorac Surg; 2013 Nov; 17(5):845-53. PubMed ID: 23900381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient and Facility Demographics Related Outcomes in Early-Stage Non-Small Cell Lung Cancer Treated with Radiofrequency Ablation: A National Cancer Database Analysis.
    Lam A; Yoshida EJ; Bui K; Katrivesis J; Fernando D; Nelson K; Abi-Jaoudeh N
    J Vasc Interv Radiol; 2018 Nov; 29(11):1535-1541.e2. PubMed ID: 30293735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propensity score-based analysis of stereotactic body radiotherapy, lobectomy and sublobar resection for stage I non-small cell lung cancer.
    Kishi N; Matsuo Y; Menju T; Hamaji M; Nakakura A; Hanazawa H; Takehana K; Date H; Mizowaki T
    J Radiat Res; 2022 Sep; 63(5):758-771. PubMed ID: 35818291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublobar Resection versus Stereotactic Body Radiation Therapy for Clinical Stage I Non-Small Cell Lung Cancer: A Study Using Data from the Korean Nationwide Lung Cancer Registry.
    Yun J; Cho JH; Hong TH; Yang K; Ahn YC; Kim HK; ;
    Cancer Res Treat; 2023 Oct; 55(4):1171-1180. PubMed ID: 37080606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Propensity-Matched Analysis of Outcomes of Patients with Clinical Stage I Non-Small Cell Lung Cancer Treated surgically or with stereotactic radiotherapy: A Meta-Analysis.
    Wen SW; Han L; Lv HL; Xu YZ; Li ZH; Wang MB; Zhu YG; Su P; Tian ZQ; Zhang YF
    J Invest Surg; 2019 Jan; 32(1):27-34. PubMed ID: 28985095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
    Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.
    Kwan SW; Mortell KE; Talenfeld AD; Brunner MC
    J Vasc Interv Radiol; 2014 Jan; 25(1):1-9.e1. PubMed ID: 24365502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublobar Resection, Radiofrequency Ablation or Radiotherapy in Stage I Non-Small Cell Lung Cancer.
    Safi S; Rauch G; op den Winkel J; Kunz J; Schneider T; Bischof M; Heussel CP; Huber PE; Herth FJ; Dienemann H; Hoffmann H
    Respiration; 2015; 89(6):550-7. PubMed ID: 25968471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer.
    Hamaji M; Chen F; Matsuo Y; Kawaguchi A; Morita S; Ueki N; Sonobe M; Nagata Y; Hiraoka M; Date H
    Ann Thorac Surg; 2015 Apr; 99(4):1122-9. PubMed ID: 25661580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definitive treatment patterns and survival in stage II non-small cell lung cancer.
    Yan SX; Qureshi MM; Suzuki K; Dyer M; Truong MT; Litle V; Mak KS
    Lung Cancer; 2018 Oct; 124():135-142. PubMed ID: 30268452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-Treatment Mortality After Surgery and Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer.
    Stokes WA; Bronsert MR; Meguid RA; Blum MG; Jones BL; Koshy M; Sher DJ; Louie AV; Palma DA; Senan S; Gaspar LE; Kavanagh BD; Rusthoven CG
    J Clin Oncol; 2018 Mar; 36(7):642-651. PubMed ID: 29346041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsimulation model predicts survival benefit of radiofrequency ablation and stereotactic body radiotherapy versus radiotherapy for treating inoperable stage I non-small cell lung cancer.
    Tramontano AC; Cipriano LE; Kong CY; Shepard JA; Lanuti M; Gazelle GS; McMahon PM
    AJR Am J Roentgenol; 2013 May; 200(5):1020-7. PubMed ID: 23617484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic Body Radiation Therapy Versus Nonradiotherapeutic Ablative Procedures (Laser/Cryoablation and Electrocautery) for Early-Stage Non-Small Cell Lung Cancer.
    Baine MJ; Sleightholm R; Neilsen BK; Oupický D; Smith LM; Verma V; Lin C
    J Natl Compr Canc Netw; 2019 May; 17(5):450-458. PubMed ID: 31085762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC.
    Ackerson BG; Tong BC; Hong JC; Gu L; Chino J; Trotter JW; D'Amico TA; Torok JA; Lafata K; Chang C; Kelsey CR
    Lung Cancer; 2018 Nov; 125():185-191. PubMed ID: 30429018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.